Financial Analyst (32-40 hours p/w)
For their office located in Oss, The Netherlands, we are looking for a Financial Analyst with sense for business. You will report directly to the Vice President Finance Europe and supports him/her in planning & control activities and in improvement projects.
As a Financial Analyst you will be responsible for analyzing the correctness, timeliness, and completeness of the financial accounts of Certara’s European and Asia Pacific entities.
A few of the main tasks are executing all activities to follow Transfer Pricing policies and prepare and analyze monthly reporting such as revenue and expense, sales, and customer level reporting for the EU and APAC entities.
It is in your nature to spot opportunities for improvement in procedures and processes. You develop new and update current dashboards for useful management information in compliance with regulations and procedures.
You are used to work within an international environment for at least 5 years and have experience in Financial Analysis and Reporting and have knowledge of project accounting. You are the point of contact for several parties such as outside accounting firms and other Certara companies.
A big plus is if you are familiar with Netsuite (Oracle based), Mavenlink (project management) or Salesforce (CRM). You are an advanced user of MS Excel.
Furthermore, you have excellent communication skills, are self-motivated and you are used to handle multiple demands with a sense of urgency. As the company language is English you are required to master this language well. The local language is Dutch.
Their unique portfolio of best-of-breed software and services along with 1000+ strong team of scientists and subject matter experts enable informed decision-making, higher R&D productivity, and improved patient outcomes.
Certara works across all therapeutic areas and innovative therapies, including immuno-oncology, rare disease, CNS, respiratory disease, gene therapy, and global health, providing translational solutions from discovery to patient access.